The Danish Medicines Agency has issued guidance on the opportunities and challenges associated with conducting decentralized clinical trials that allow patients to participate in research from their homes.
The guideline reflects the knowledge and feedback that the Danish regulator has gathered from an ongoing national project on decentralized...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?